Arkolith/Insider Trading/OPNT/Form 4

Ellison Mark Jason Heath

Chief Development OfficerOPIANT PHARMACEUTICALS, INC. (OPNT) · full profile →Form 4 · filed Jan 9, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$9K
Net Open-Market Flow
-$9K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 9, 2023Sell(S)469$20.20$9K19K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001385508-23-000022) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML